期刊文献+

培美曲塞和多西他赛分别联合适形大分割放疗治疗局部晚期老年非小细胞肺癌的疗效比较 被引量:1

Comparison on the therapeutic effects of pemetrexed and docetaxel respectively combined with conformal hypofractionated radiation therapy for old patients with local advanced non-small cell lung cancer
下载PDF
导出
摘要 目的比较培美曲塞和多西他赛分别联合同期适形大分割放疗治疗局部晚期老年非小细胞肺癌(NSCLC)的近期疗效和不良反应。方法根据治疗方式的不同,将57例老年NSCLC患者分为培美曲塞组和多西他赛组。培美曲塞组接受培美曲塞联合同期适形大分割放疗,多西他赛组接受多西他赛联合同期适形大分割放疗,评估2组近期疗效和不良反应。结果培美曲塞组总有效率和1年生存率均略高于多西他赛组;2组不良反应主要包括放射性肺炎、放射性食管炎和骨髓抑制,但2组比较,差异无统计学意义。结论培美曲塞和多西他赛分别联合同期适形大分割放疗治疗NSCLC疗效相当,且不良反应较少,老年患者可耐受。 Objective To compare the short-term therapeutic effects and adverse reactions of pemetrexed and docetaxel respectively combined with conformal hypofractionated radiation therapy at the same term for old patients with local advanced non-small cell lung cancer(NSCLC).Methods According to different treatment methods,57 old patients with NSCLC were divided into pemetrexed group and docetaxel group.Pemetrexed group was treated with pemetrexed combined with conformal hypofractionated radiation therapy,while docetaxel group with docetaxel combined with conformal hypofractionated radiation therapy.The short-term therapeutic effects and adverse reactions of two groups were compared.Results The total effectiveness rate and one-year survival rate of pemetrexed group were slightly higher than those of docetaxel group.The adverse reactions of two groups mainly included radiation pneumonitis,radiation esophagitis and myelosuppression.But compared with the adverse reactions of two groups,the difference showed no statistical significance.Conclusion Pemetrexed and docetaxel respectively combined with conformal hypofractionated radiation therapy at the same term in the treatment of old patients with NSCLC have similar therapeutic effects,less adverse reactions,and can be tolerated by old patients.
出处 《实用临床医药杂志》 CAS 2013年第13期45-47,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11320118)
关键词 培美曲塞 多西他赛 大分割放疗 非小细胞肺癌 pemetrexed docetaxel hypofractionated radiation therapy non-small cell lung cancer
  • 相关文献

参考文献12

  • 1Greenlee R T, Murray T, []olden S, et al. Cancer statistics [J]. CA Cancer J Clin, 2000, 50(1) ; 7.
  • 2殷蔚伯,余子豪,徐国镇,等.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社,2007:546-574.
  • 3Kauffmann M, Kriiger T, Aebert H. Surgery on extracorpo- real circulation in early and advanced non - small cell lung cancer[J]. Thorac Cardiovasc Surg, 2013, 61(2) : 103.
  • 4Nestle U, Nieder C, Walter K, et al. A palliative accelerated irradiation regimen for advanced non - small cell lung cancer vs. conventionally fractionated 60 Gy: results of a random- ized equivalence study [ J ]. Int J Radiat Oncol Biol Phys, 2000, 48(1): 95.
  • 5Lan D, Leigh/3, Gandara D, et al. Twice - weekly paclitax- el and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage :lI non- small - cell lung cancer: a California cancer consortium phase 1I trial[J]. J Clin Oncol, 2001, 19(2): 442.
  • 6Seder C W, Allen M S, Cassivi S D, et al. Stage l]Ia non- small cell lung cancer: morbidity and mortality of three dis- tinct multimodality regimens[J]. Ann Thorac Surg, 2013, 95(5): 1708.
  • 7Nogueira A, Assis J, Catarino R, et al, DNA repair and cy- totoxic drugs: the potential role of RAI351 in clinical outcome of non - small - cell lung cancer patients [ J ]. Pharmacoge- nomies, 2013, 14(6): 689.
  • 8Calvert H. An overview of folate metabolism: features relevgntto the action and toxieities of antifolate anticancer a- gents[J]. Semin Oncol, 1999, 26,2(supp16): 3.
  • 9Lee D S, Kim Y S, Kang J H, et al. Clinical responses and prognostic indicators of concurrent chemoradiation for non- small cell lung cancer[J ]. Cancer Res Treat, 2011, 43 (1) : 32.
  • 10Li C M, Lu Y, Chen J, et al. Orally bioavailable tubulin an- tagonists for paclitaxel - refractory cancer [ J ]. Pharm Res, 2012, 29(11): 3053.

二级参考文献1

共引文献177

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部